$
22.30
10:09 PM EST
Business Description
Kaken Pharmaceutical Co Ltd
NAICS : 325411
SIC : 2833
ISIN : JP3207000005
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.18 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 1.13 | |||||
Interest Coverage | 249 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5 | |||||
Beneish M-Score | -2.63 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.2 | |||||
3-Year EBITDA Growth Rate | -30.3 | |||||
3-Year EPS without NRI Growth Rate | -28.2 | |||||
3-Year FCF Growth Rate | -33.8 | |||||
3-Year Book Growth Rate | 3.3 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 0.02 | |||||
14-Day RSI | 0.14 | |||||
6-1 Month Momentum % | -18.16 | |||||
12-1 Month Momentum % | -18.16 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.64 | |||||
Quick Ratio | 4.68 | |||||
Cash Ratio | 3.38 | |||||
Days Inventory | 188.74 | |||||
Days Sales Outstanding | 114.74 | |||||
Days Payable | 81.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.51 | |||||
Dividend Payout Ratio | 1.51 | |||||
Forward Dividend Yield % | 4.44 | |||||
5-Year Yield-on-Cost % | 4.51 | |||||
3-Year Average Share Buyback Ratio | 1.3 | |||||
Shareholder Yield % | 4.31 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 53.89 | |||||
Operating Margin % | 6.22 | |||||
Net Margin % | 4.11 | |||||
FCF Margin % | 10.36 | |||||
ROE % | 2.14 | |||||
ROA % | 1.76 | |||||
ROIC % | 4.46 | |||||
ROC (Joel Greenblatt) % | 6.97 | |||||
ROCE % | 2.31 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 44.57 | |||||
PE Ratio without NRI | 32.55 | |||||
Shiller PE Ratio | 8.71 | |||||
PS Ratio | 1.82 | |||||
PB Ratio | 0.94 | |||||
Price-to-Tangible-Book | 0.99 | |||||
Price-to-Free-Cash-Flow | 18.54 | |||||
Price-to-Operating-Cash-Flow | 14.12 | |||||
EV-to-EBIT | 20.33 | |||||
EV-to-EBITDA | 20.33 | |||||
EV-to-Revenue | 0.96 | |||||
EV-to-FCF | 9.85 | |||||
Price-to-Projected-FCF | 0.52 | |||||
Price-to-Median-PS-Value | 0.79 | |||||
Price-to-Graham-Number | 1.2 | |||||
Price-to-Net-Current-Asset-Value | 1.6 | |||||
Price-to-Net-Cash | 3.47 | |||||
Earnings Yield (Greenblatt) % | 4.92 | |||||
FCF Yield % | 5.35 | |||||
Forward Rate of Return (Yacktman) % | -6.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KKPCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kaken Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 509.133 | ||
EPS (TTM) ($) | 0.491 | ||
Beta | 0.02 | ||
Volatility % | 19.83 | ||
14-Day RSI | 0.14 | ||
14-Day ATR ($) | 0.033052 | ||
20-Day SMA ($) | 22.38275 | ||
12-1 Month Momentum % | -18.16 | ||
52-Week Range ($) | 22.3 - 29.27 | ||
Shares Outstanding (Mil) | 37.87 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kaken Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kaken Pharmaceutical Co Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Kaken Pharmaceutical Co Ltd Frequently Asked Questions
What is Kaken Pharmaceutical Co Ltd(KKPCF)'s stock price today?
When is next earnings date of Kaken Pharmaceutical Co Ltd(KKPCF)?
Does Kaken Pharmaceutical Co Ltd(KKPCF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |